Clinical Trials
Clinical Trials
Clinical Trials
Date
Page
03-03 2022
linical Tuas
Blindud study2 maurlam sOmodemzauen
a:dm Uals Ae Yallimb au gvem Nlacebe
akjillb alHNde
30.0322
hi acrly
efa compocnd
Aolubon
xonhylaclc Muals
hiy re fuevenlave uala hal dlforuom
olv clenucal vala as luq.
huallhy sMeojecls t Mdyeols ckydilul
hemk ueas ualthu
26O4 2
Lenal Pmeyles fhuayuuae ugl
She olloaung ava gnvalfuunciplbs lo
ovkvrol infilannlng nd coneiucleng a goo
slud
i)Corufllomuulalon af he qpasuons for whurk
uckseamswes AMNauwud
i&cson on lhe mojt apuepual oms
tias(conbols), fruefpcally lo jlkdy
COncwounly
ni) hu essence a conbolud biols lhal pa
COnpanolk sludy muyl bemad higmw
átmenl shoulett pomnawdmlh a
hatmacdogically bnued Auyanalion lo ehech
chetheor Hoa a y yrucinoh efeol on he
hneas
w)otlecluonel paluims for ricleson pin he bial
bcleru A h r o n hs lo Ashioh bualmnt
oyn hey uvill eAnelucled ik: q1aluink shosdd
OCe alloted Jo lht Aruals al nanddem
heneuen frendbu Jon subjicuive enaluahn,
uals shouled e. aordnged that neilheu t
hyscon me ih Youent,knocs Lohuch
amwlvwd Ths s u .
ualmeml As bnq m d Ayslum o n l .
knaenas Aoult
hifoOON ANO mg
n d and Avhen
buned, hm t d L
dalo s abo ky
ujnh dmd'syiern:
deéMOn On htmcua and m hed ofnah
vi) abverahohs o n l
systnalhc amcd tvilnent
awaulal
fratuntaAO Ahal ulwanl dala u
n a l y s Ol hu snd.f ual alemgwilh
vi) cmensn he pecedush 4
ond dovalns pvenW hicosign
utlhonowah
hal ows Ahvung h1 buials
dhnens ON ddla fuocimurq Alalhral
vi) h
pdnchunon
AMalysaAnd on awvmg
Lirlertnces
bualmnl
hiams o pllocal sulbjicthlo lh hat
lucha way
md conbuol qrouns Am in all
h o y n Du Lmiially sGuNatr
Rsptels tliwani lo he prauvy.
alon yem ingn
X
o hecvratonsom he
Suluauomd eaduna
LOntmen
U NOT
AUOCLlwus KauolHown
uch
Auuing he tcuon Adeigns
yuoctid.
XHoA-SLCluenal Muchi
uoN-sUCuonal sudy does mot take he
Umyoal ulatuonsh kUem hu faco
saudliolmle accAmi: Mually MAhwewes
he Lnammaluon LaAOISAlon l a
Aranlilan epulhtiom at mLpaviudulan
Ontam : HON:MAonal jtuoliis masy
L bastd on uandom sanmplu jema V
dlnicdJropulalm LOna putésnlio
Abmryli o paltml stlh a fianiiaular
AmYnlenLd AO uchy aYVOOon khwn
ulennt dsaslconduuóns; houever luy
CAhnolLn addvminu whuch doass
mghi{
htin ccwvd fust
06-0522
4 n tms afennlainingdiion ymoloqy,
buy vuovtole eny liilited inlohatiorl h2
uNalma a diseas tan bececdli
dned AA AhiJbporluon of humans uhe
hbve th Oiat
*omludundlsluchis-
i oyauclive sudis s Ale knoun asu
Ochwt Audiis;Ancidce gOllcw u
studuis: hvu ouLus kqyssudhis kosed
i)ymeleqcal sucy2hou ni Alarts
Aslhamimiually2hallhy 2hud o
Amadcualakapoud te fownt
lvclse suyiofid suskhtclor pa
Causluhe au ollocdtim to
llvmure he kibegwm mcidene
ii)Ploqnesuisud huu patim uth
astucc disal Jolloud yn ig9
dlontint utiuehaers pelatu to
husn morlaalhiis gmolaliy
ORa/c aC
b/d bc
OR alse ulpud to as Kisk pdA 2oti
xkauéackse ulueyuclieAtudy
aelirumbralon elypefulalidn Lom uhuet
i)h oiuoial slih m ht
hfauuns com hs
g n ef PUbropecln sluue.
AKAJECaUilakir Aamp ef nefulaom A
A4CL Amporlamt dmy mllakes Ommulecl
ct
AhiS sla wil Amtusuuce bas mi he
elaubnskaja
here t 3 milhcds for choevinq pontuol
LOYNA:
)Pamadem Aamnlug
i pcknuaui f mmaWhung
alumb' wh Ahvl cleoses
x onkcdenc gnluNal Lou OddsRalu
as'un thu cak eLsouynue slausuos OR
alse subyecl Ad Anplarq wue: hu
landand
oplLa
6 E(OR)=ORx t+
ab
Thsas waid ndvn
al Alandand näaken m 2x21
Mowenackl
Auhn Íhe matwnd Wolt milha can bt usd
LOnmdvud to kmdLeghrutihm
SE(OR). e
el OR A%
EOR9=
5 E(n OB
951 l
nonicnce L kn OR Can ke
LKOR 146 SElkn sttained q
OR)
hi Amtewal islunmatus el OR au dvwcd as
Knliloq Aabove ctnhdena bmis.
05: 2
isk ador
And RK-T)= once m hi Ancidine ef
ssay leluveek pteplk usheadLYOd
le Thi pisk Lactornd Kfhox Lché A nt